E303-1001S: A Phase I/II, Open-label, Multi-center, First-in-human Trial to Investigate E303 in Participants with Unresectable or Metastatic Solid Tumors and Urothelial Carcinoma


  • Enrollment

    This study is not currently enrolling.
  • Sponsor

    Samsung Bioepis Co., Ltd.